SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Pacira BioSciences, Inc. – ‘10-K’ for 12/31/17 – ‘ZIP’

On:  Wednesday, 2/28/18, at 3:05pm ET   ·   For:  12/31/17   ·   Accession #:  1396814-18-9   ·   File #:  1-35060

Previous ‘10-K’:  ‘10-K’ on 3/1/17 for 12/31/16   ·   Next:  ‘10-K’ on 2/28/19 for 12/31/18   ·   Latest:  ‘10-K’ on 2/29/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/28/18  Pacira BioSciences, Inc.          10-K       12/31/17   87:10M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.15M 
 2: EX-10.14    Material Contract                                   HTML    122K 
 3: EX-21.1     Subsidiaries List                                   HTML     21K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     24K 
 5: EX-23.2     Consent of Experts or Counsel                       HTML     24K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
16: R1          Document and Entity Information                     HTML     50K 
17: R2          Consolidated Balance Sheets                         HTML    108K 
18: R3          Consolidated Balance Sheets (Parenthetical)         HTML     43K 
19: R4          Consolidated Statements of Operations               HTML     91K 
20: R5          Consolidated Statements of Comprehensive Income     HTML     36K 
                (Loss)                                                           
21: R6          Consolidated Statements of Stockholders' Equity     HTML     96K 
22: R7          Consolidated Statements of Cash Flows               HTML    119K 
23: R8          Description of Business                             HTML     28K 
24: R9          Summary of Significant Accounting Policies          HTML    120K 
25: R10         Recent Accounting Pronouncements                    HTML     43K 
26: R11         Inventories                                         HTML     33K 
27: R12         Fixed Assets                                        HTML     43K 
28: R13         Goodwill and Intangible Assets                      HTML     41K 
29: R14         Accrued Expenses                                    HTML     35K 
30: R15         Debt                                                HTML     89K 
31: R16         Financial Instruments                               HTML    102K 
32: R17         Stockholders' Equity                                HTML     34K 
33: R18         Stock Plans                                         HTML    177K 
34: R19         Net Income (Loss) Per Share                         HTML     70K 
35: R20         Income Taxes                                        HTML    111K 
36: R21         Other Employee Benefits                             HTML     27K 
37: R22         Commercial Partners and Other Agreements            HTML     66K 
38: R23         Related Party Transactions                          HTML     31K 
39: R24         Commitments and Contingencies                       HTML     43K 
40: R25         Selected Quarterly Financial Data (Unaudited)       HTML     63K 
41: R26         Summary of Significant Accounting Policies          HTML    200K 
                (Policies)                                                       
42: R27         Summary of Significant Accounting Policies          HTML     86K 
                (Tables)                                                         
43: R28         Inventories (Tables)                                HTML     33K 
44: R29         Fixed Assets (Tables)                               HTML     37K 
45: R30         Goodwill and Intangible Assets (Tables)             HTML     32K 
46: R31         Accrued Expenses (Tables)                           HTML     34K 
47: R32         Debt (Tables)                                       HTML     60K 
48: R33         Financial Instruments (Tables)                      HTML     93K 
49: R34         Stockholders' Equity (Tables)                       HTML     31K 
50: R35         Stock Plans (Tables)                                HTML    138K 
51: R36         Net Income (Loss) Per Share (Tables)                HTML     71K 
52: R37         Income Taxes (Tables)                               HTML     76K 
53: R38         Commercial Partners and Other Agreements            HTML     47K 
                Commerical Partners and Other Agreements (Tables)                
54: R39         Commitments and Contingencies (Tables)              HTML     33K 
55: R40         Selected Quarterly Financial Data (Unaudited)       HTML     63K 
                (Tables)                                                         
56: R41         Summary of Significant Accounting Policies          HTML     26K 
                (Details)                                                        
57: R42         Summary of Significant Accounting Policies Summary  HTML     44K 
                of Significant Accounting Policies (Details 2)                   
58: R43         Summary of Significant Accounting Policies          HTML     37K 
                (Details 3)                                                      
59: R44         Summary of Significant Accounting Policies          HTML     37K 
                (Details 4)                                                      
60: R45         RECENT ACCOUNTING PRONOUNCEMENTS Recent Accounting  HTML     26K 
                Pronouncements (Details)                                         
61: R46         Inventories (Details)                               HTML     36K 
62: R47         Fixed Assets (Details)                              HTML     59K 
63: R48         Goodwill and Intangible Assets (Details)            HTML     65K 
64: R49         Goodwill and Intangible Assets Schedule of          HTML     26K 
                Intangible Assets (Details)                                      
65: R50         Accrued Expenses (Details)                          HTML     35K 
66: R51         Debt (Details)                                      HTML    157K 
67: R52         Debt (Details 2)                                    HTML     40K 
68: R53         Financial Instruments (Details)                     HTML     75K 
69: R54         Financial Instruments (Details 2)                   HTML     60K 
70: R55         Financial Instruments (Details 3)                   HTML     36K 
71: R56         Stockholders' Equity (Details)                      HTML     29K 
72: R57         Stockholders' Equity (Details 2)                    HTML     35K 
73: R58         Stock Plans (Details)                               HTML     71K 
74: R59         Stock Plans (Details 2)                             HTML     43K 
75: R60         Stock Plans (Details 3)                             HTML    155K 
76: R61         Net Income (Loss) Per Share (Details)               HTML     58K 
77: R62         Net Income (Loss) Per Share (Details 2)             HTML     39K 
78: R63         Income Taxes (Details)                              HTML    151K 
79: R64         Other Employee Benefits (Details)                   HTML     25K 
80: R65         Commercial Partners and Other Agreements (Details)  HTML    120K 
81: R66         Related Party Transactions (Details)                HTML     43K 
82: R67         Commitments and Contingencies (Details)             HTML     52K 
83: R68         Commitments and Contingencies (Details 2)           HTML     34K 
84: R69         Selected Quarterly Financial Data (Unaudited)       HTML     39K 
                (Details)                                                        
86: XML         IDEA XML File -- Filing Summary                      XML    149K 
85: EXCEL       IDEA Workbook of Financial Reports                  XLSX    105K 
10: EX-101.INS  XBRL Instance -- pcrx-20171231                       XML   2.70M 
12: EX-101.CAL  XBRL Calculations -- pcrx-20171231_cal               XML    245K 
13: EX-101.DEF  XBRL Definitions -- pcrx-20171231_def                XML    713K 
14: EX-101.LAB  XBRL Labels -- pcrx-20171231_lab                     XML   2.02M 
15: EX-101.PRE  XBRL Presentations -- pcrx-20171231_pre              XML   1.07M 
11: EX-101.SCH  XBRL Schema -- pcrx-20171231                         XSD    203K 
87: ZIP         XBRL Zipped Folder -- 0001396814-18-000009-xbrl      Zip    286K 


‘ZIP’   —   XBRL Zipped Folder — 0001396814-18-000009-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:pcrx-20171231.xml
pcrx-20171231.xsd
pcrx-20171231_cal.xml
pcrx-20171231_def.xml
pcrx-20171231_lab.xml
pcrx-20171231_pre.xml

Top
Filing Submission 0001396814-18-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 11:04:44.1am ET